Advertisement
Screener

Q/C Technologies, Inc. (QCLS) Cash and Cash Equivalents, Period Increase (Decrease)

1.2 / 5 stars · 16/66 Roast Me

Q/C Technologies, Inc. Cash and Cash Equivalents, Period Increase (Decrease)

Q/C Technologies, Inc. (QCLS) reported Cash and Cash Equivalents, Period Increase (Decrease) of $208.84 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-07-13.

Discontinued › Cash Flow

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-07-13

  • Q/C Technologies, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $208.84K, a 89.62% decline year-over-year.
  • Q/C Technologies, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $303.30K.
  • Q/C Technologies, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$62.04K.
  • Q/C Technologies, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$1.89M, a 1048.03% decline year-over-year.
  • Q/C Technologies, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $365.73K.
  • Q/C Technologies, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$329.36K.
  • Q/C Technologies, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$53.78K, a 115.27% decline from fiscal 2014.
  • Q/C Technologies, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $352.21K.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2018-03-31$208.84K
10-Q · filed 2018-07-13
$512.13K
derived: sum of 2 quarters · filed 2018-07-13
$450.09K
derived: sum of 3 quarters · filed 2018-07-13
-$1.44M
derived: sum of 4 quarters · filed 2018-07-13
2017-12-31$303.30K
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-07-13
$241.26K
derived: sum of 2 quarters · filed 2018-07-13
-$1.65M
derived: sum of 3 quarters · filed 2018-07-13
$365.73K
10-K/A · filed 2018-07-13
2017-09-30-$62.04K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-07-13
-$1.95M
derived: sum of 2 quarters · filed 2018-07-13
$62.43K
10-Q/A · filed 2018-07-13
-$60.73K
derived: sum of 4 quarters · filed 2018-07-13
2017-06-30-$1.89M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-07-13
$124.47K
10-Q/A · filed 2018-07-13
$1.31K
derived: sum of 3 quarters · filed 2018-07-13
-$182.36K
derived: sum of 4 quarters · filed 2018-07-13
2017-03-31$2.01M
10-Q · filed 2018-07-13
$1.89M
derived: sum of 2 quarters · filed 2018-07-13
$1.71M
derived: sum of 3 quarters · filed 2018-07-13
$1.90M
derived: sum of 4 quarters · filed 2018-07-13
2016-12-31-$123.16K
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-07-13
-$306.83K
derived: sum of 2 quarters · filed 2018-07-13
-$107.69K
derived: sum of 3 quarters · filed 2018-07-13
-$329.36K
10-K/A · filed 2018-07-13
2016-09-30-$183.67K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-07-13
$15.47K
derived: sum of 2 quarters · filed 2018-07-13
-$206.20K
10-Q/A · filed 2018-07-13
-$197.51K
derived: sum of 4 quarters · filed 2018-07-13
2016-06-30$199.14K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-07-13
-$22.53K
10-Q/A · filed 2018-07-13
-$13.84K
derived: sum of 3 quarters · filed 2018-07-13
$118.30K
derived: sum of 4 quarters · filed 2018-07-13
2016-03-31-$221.67K
10-Q · filed 2017-05-15
-$212.98K
derived: sum of 2 quarters · filed 2017-05-15
-$80.84K
derived: sum of 3 quarters · filed 2017-05-15
-$155.85K
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$8.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11
$140.82K
derived: sum of 2 quarters · filed 2017-04-11
$65.82K
derived: sum of 3 quarters · filed 2017-04-11
-$53.78K
10-K · filed 2017-04-11
2015-09-30$132.14K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$57.13K
derived: sum of 2 quarters · filed 2016-11-14
-$62.47K
10-Q · filed 2016-11-14
-$249.14K
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30-$75.01K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
-$194.61K
10-Q · filed 2016-08-11
-$381.28K
derived: sum of 3 quarters · filed 2016-08-11
-$141.05K
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31-$119.60K
10-Q · filed 2016-05-12
-$306.27K
derived: sum of 2 quarters · filed 2016-05-12
-$66.04K
derived: sum of 3 quarters · filed 2016-05-12
$30.43K
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31-$186.67K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$53.56K
derived: sum of 2 quarters · filed 2016-03-30
$150.03K
derived: sum of 3 quarters · filed 2016-03-30
$352.21K
10-K · filed 2016-03-30
2014-09-30$240.23K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
$336.71K
derived: sum of 2 quarters · filed 2015-11-13
$538.88K
10-Q · filed 2015-11-13
-$38.72K
derived: sum of 4 quarters · filed 2015-11-13
2014-06-30$96.47K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-18
$298.65K
10-Q · filed 2015-08-18
-$278.95K
derived: sum of 3 quarters · filed 2015-08-18
-$1.15M
derived: sum of 4 quarters · filed 2015-08-18
2014-03-31$202.18K
10-Q · filed 2015-05-14
-$375.43K
derived: sum of 2 quarters · filed 2015-05-14
-$1.25M
derived: sum of 3 quarters · filed 2015-05-14
-$215.69K
derived: sum of 4 quarters · filed 2015-05-14
2013-12-31-$577.60K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23
-$1.45M
derived: sum of 2 quarters · filed 2015-03-23
-$417.87K
derived: sum of 3 quarters · filed 2015-03-23
-$529.39K
10-K · filed 2015-03-23
2013-09-30-$872.65K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
$159.74K
derived: sum of 2 quarters · filed 2014-11-13
$48.22K
10-Q · filed 2014-11-13
2013-06-30$1.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$920.86K
10-Q · filed 2014-08-12
2013-03-31-$111.52K
10-Q · filed 2014-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
BIOMERICA INC (BMRA)United States$0.011B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92